Biomatrix (BXM) Looking Great Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biomatrix (BXM) Looking Great

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Ted The Technician who wrote (544)	10/24/1999 10:12:00 PM
From: James Baker	Read Replies (1) of 569

BXM has stated that in preparation for the direct marketing push during the 3rd Qt they and W-A wanted to have a 90 day supple of Synvisc in the pipeline. This would account for the higher than needed sales in the second cqt. I think the most significant factor is that sales to the end users increased 40% qt to qt . This is the most important factor in the long run. WSJ in the Heard on the Net column 10/22 reviews all of the lies out there about synvisc. Analysts, competitors as well as BXM and W-A all say this is nonsense. the short interest in this stock is huge at 5 mill shares. Float is only 14.2 mill shares. I have been in BXM for several years and thinks it has a great future. discussion of new products in recent news release very nice to see.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next